Unicycive Therapeutics, Inc
  • About
    • Our Story
    • Our Focus
    • Our Team
    • Board of Directors
  • Our Science
    • Our Approach
    • Pipeline
    • Oxylanthanum Carbonate (OLC)
    • UNI-494
    • Publications & Press
  • Investors
  • Contact
    • Careers

Governance Documents

Investors

Investors

  • Overview
  • News
  • Events & Presentations
    • IR Calendar
    • Presentations
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Financial & Stock Info
    • Overview
    • Financial Results
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Resources
    • Overview
    • Contacts
    • FAQ
    • Email Alerts
  • Governance

  • Overview
  • Management Team
  • Board of Directors
  • Board Committees
  • Governance Documents

Audit Committee Charter

Download Audit Committee Charter

Compensation Committee Charter

Download Compensation Committee Charter

Nominating and Corporate Governance Committee Charter

Download Nominating and Corporate Governance Committee Charter

Code of Business Conduct and Ethics

Download Code of Business Conduct and Ethics
  • Email Alerts
  • Contacts
  • RSS News Feed
Unicycive Theraputics, Inc

About
Our story
Our focus
Our team
Boards of Directors
Careers

Technology
Therapeutic approach
Therapeutic pipeline
OLC
UNI-494

Publications & Press

Investors
Contact

4300 El Camino Real, Suite #210
Los Altos, CA 94022
+1 (650) 351-4495
info@unicycive.com

  • LinkedIn
  • YouTube
  • Facebook
  • Instagram
  • Twitter

Copyright © 2025 Unicycive

Legal Notices and Terms of Use Privacy Policy Ad and Cookie Policy